Quest Diagnostics Reports Strong Q2 Earnings and Raises Guidance

Quest Diagnostics (DGX) shares rose approximately 11% after the diagnostic testing company reported second-quarter earnings that exceeded Wall Street estimates. The firm also raised its full-year guidance for 2026 above consensus expectations.

By Preeti Singh, SA News Editor · Seeking Alpha ·

Quest Diagnostics Reports Strong Q2 Earnings and Raises Guidance

Tickers: $DGX

Topics: earnings guidance update stock price movement

Read the full article at Seeking Alpha

More World news